Nucleoside

Results: 353



#Item
171Division: Pharmacy Services  Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Add to Reading List

Source URL: www.fdhc.state.fl.us

Language: English - Date: 2013-12-30 12:41:58
172PRIORITY ANTIRETROVIRALS FOR THE MEDICINES PATENT POOL Abridged Version | Third Edition | December 2013 Advancing innovation, access, and public health

PRIORITY ANTIRETROVIRALS FOR THE MEDICINES PATENT POOL Abridged Version | Third Edition | December 2013 Advancing innovation, access, and public health

Add to Reading List

Source URL: www.medicinespatentpool.org

Language: English - Date: 2014-03-10 11:29:27
173Dh’OX YRIBON UCLEIC ACID-DIRECTED SYNTHESIS OF RIBONUCLEIC ACID BY AN ENZYME FROM ESCHERICHIA COLI* BY MICHAEL CHAMBERLINt

Dh’OX YRIBON UCLEIC ACID-DIRECTED SYNTHESIS OF RIBONUCLEIC ACID BY AN ENZYME FROM ESCHERICHIA COLI* BY MICHAEL CHAMBERLINt

Add to Reading List

Source URL: profiles.nlm.nih.gov

Language: English - Date: 2008-03-07 14:40:10
174Enzymatic Synthesis of Deoxyribonucleic Acid I. PREPARATION O F SUBSTRATES AND PARTIAL PURIFICATION OF AN ENZYME FROM ESCHERICHIA COLI I. R. LEHMAN,* MAURICEJ. BESSMAN,~ ERNESTS. SIMMS,AND ARTHURKOHNBERG

Enzymatic Synthesis of Deoxyribonucleic Acid I. PREPARATION O F SUBSTRATES AND PARTIAL PURIFICATION OF AN ENZYME FROM ESCHERICHIA COLI I. R. LEHMAN,* MAURICEJ. BESSMAN,~ ERNESTS. SIMMS,AND ARTHURKOHNBERG

Add to Reading List

Source URL: profiles.nlm.nih.gov

Language: English - Date: 2007-06-08 15:44:56
175Microsoft Word - CROI 2014 exposed infant final color logo.docx

Microsoft Word - CROI 2014 exposed infant final color logo.docx

Add to Reading List

Source URL: nccc.ucsf.edu

Language: English - Date: 2014-05-20 12:14:26
176NDA[removed]NDA[removed]Page 6 Baraclude™

NDA[removed]NDA[removed]Page 6 Baraclude™

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 15:18:19
177Capital Health Inside this Issue….. Additions to Formulary Rilpivirine, Edurant® Rilpivirine/Tenofovir/Emtricitabine, Complera® Revised Restrictions

Capital Health Inside this Issue….. Additions to Formulary Rilpivirine, Edurant® Rilpivirine/Tenofovir/Emtricitabine, Complera® Revised Restrictions

Add to Reading List

Source URL: www.cdha.nshealth.ca

Language: English - Date: 2014-10-02 06:10:07
178AIDS InfoNet  www.aidsinfonet.org Fact Sheet Number 431

AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 431

Add to Reading List

Source URL: www.aidsinfonet.org

Language: English - Date: 2014-04-16 14:34:58
179Non-nucleoside reverse transcriptase inhibitors / Cyclopropanes / Biology / Lactams / Nevirapine / Pyridines / Antiretroviral drug / Reverse-transcriptase inhibitor / HIV / Chemistry / Organic chemistry / HIV/AIDS

AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 431 NEVIRAPINE (Viramune) WHAT IS NEVIRAPINE?

Add to Reading List

Source URL: www.aidsinfonet.org

Language: English - Date: 2014-04-16 14:34:58
180TB_MedicationDrugFoodInteraction_(edited)

TB_MedicationDrugFoodInteraction_(edited)

Add to Reading List

Source URL: www.heartlandntbc.org

Language: English - Date: 2014-04-03 10:37:47